Compare Amphastar Pharmaceuticals Inc (AMPH) vs Global X Defense Tech ETF (SHLD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Global X Defense Tech ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $19.38 (market cap $826.08M), while Global X Defense Tech ETF trades at $60.4. Which is the better fit depends on your goals.
| AMPH | SHLD | |
|---|---|---|
Market Cap | $826.08M | — |
Sector | Health | Sector/Thematic |
52-Week High | $30.81 | $78.02 |
52-Week Low | $16.87 | $58.20 |
Enterprise Value | $1.22B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% on the day, with a bearish technical signal from moving averages. Recent earnings missed estimates in Q1 2026, with revenue of $171.2 million and adjusted EPS of $0.42 versus $0.70 expected. The company is shifting focus toward proprietary drugs and biosimilars for growth, as noted at recent investor conferences.
Outlook is mixed: valuation ratios appear reasonable with P/E of 11.29 and EV/EBITDA of 6.32, but earnings misses and a Zacks Strong Sell rating highlight near-term risks. The consensus price target of $20.40 suggests modest upside if execution improves, though legal scrutiny and competitive pressures remain concerns.
SHLD, the Global X Defense Tech ETF, trades at $61.19, down 0.44% with a bearish technical signal. The ETF faces selling pressure as moving averages indicate a downtrend, though oscillators remain neutral. Recent news highlights global defense spending growth and comparisons with peers like XAR and ITA, focusing on expense ratios and sector exposure. A dividend of $0.19 is scheduled for July 2026.
Outlook is mixed; rising military budgets globally support long-term growth, but technical weakness and competitive ETF landscape pose risks. The fund's diversified defense tech exposure may benefit from geopolitical trends, yet investors should monitor expense ratios and performance relative to alternatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Global X Defense Tech ETF
SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →
